One Equity Partners, a middle market private equity firm, has completed a strategic investment in InfuCare Rx, a national provider of specialty infusion therapies and clinical therapy management services.

InfuCare offers specialty infusion services and focuses on immunoglobin therapy, chronic inflammatory therapy, acute and anti-infective therapy, bleeding disorders and parenteral nutrition. The firm has locations across New Jersey, Pennsylvania, Maryland, Louisiana, California and Texas servicing over 4,000 patients in 43 states.

The infusion therapy sector is a $100 billion dollar industry providing care throughout hospitals, physician offices, nursing facilities and alternate site settings like ambulatory sites and the home.